Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18557594 | 1.00 | CYP3A4 (0.43) | CYP3A4CYP2C9CHRM3CYP2D6CHRM2 | |
| SCHEMBL17978820 | 0.85 | CYP2C9 (0.55) | CYP3A4CYP2C9CYP2D6KIF11 | |
| SCHEMBL17979123 | 0.85 | CYP2C9 (0.55) | CYP3A4CYP2C9CYP2D6KIF11 | |
| SCHEMBL29631326 | 0.85 | CYP2C9 (0.55) | CYP3A4CYP2C9CYP2D6KIF11 | |
| SCHEMBL17978693 | 0.85 | CYP2C9 (0.55) | CYP3A4CYP2C9CYP2D6KIF11 | |
| SCHEMBL6599026 | 0.78 | CHRM3 (0.45) | CYP2C9CHRM3CYP2D6CHRM2CHRM4 | |
| SCHEMBL19770150 | 0.78 | KCNN4 (0.51) | CHRM3CYP2D6CHRM2CHRM4CHRM5 | |
| SCHEMBL18016307 | 0.78 | KCNN4 (0.51) | CHRM3CYP2D6CHRM2CHRM4CHRM5 | |
| SCHEMBL14166571 | 0.76 | CYP2C9 (0.49) | CYP2C9KIF11MEN1KMT2A | |
| SCHEMBL9250738 | 0.75 | ELANE (0.49) | CYP2C9CHRM3CHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10004728-B2 | Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity | CHIESI FARMACEUTICI S.P.A. (IT) | 2018-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10004728-B2 | Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity | ADRB2, ADRB1, ADRA2B | CYP3A4 1015/4885CYP2C9 1422/4885CHRM3 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.